| Gene Symbol | Gene ID | Gene Info | 
|---|---|---|
| 
                            IRX3
                            
                            
                         | ENSG00000177508.11 | iroquois homeobox 3 | 
| CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot | 
|---|---|---|---|---|---|---|
| chr16_54404851_54405002 | IRX3 | 84251 | 0.098010 | -0.91 | 6.7e-04 | Click! | 
| chr16_54312818_54312969 | IRX3 | 6874 | 0.247139 | -0.80 | 9.0e-03 | Click! | 
| chr16_54407637_54408111 | IRX3 | 87199 | 0.093946 | -0.77 | 1.6e-02 | Click! | 
| chr16_54400901_54401052 | IRX3 | 80301 | 0.103914 | -0.76 | 1.7e-02 | Click! | 
| chr16_54318803_54318954 | IRX3 | 889 | 0.671776 | -0.75 | 2.1e-02 | Click! | 
Move your cursor over a bar to see sample name and corresponding Z-value.
| Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability | 
|---|---|---|---|---|---|
| chr6_143252390_143252629 | 1.98 | HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 | 13829 | 0.25 | 
| chr12_65086213_65086398 | 1.57 | AC025262.1 | Mesenchymal stem cell protein DSC96; Uncharacterized protein | 4024 | 0.18 | 
| chr3_177721729_177722186 | 1.48 | ENSG00000199858 | . | 3610 | 0.39 | 
| chr1_51447469_51447666 | 1.44 | CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 11951 | 0.2 | 
| chr12_93825039_93825190 | 1.37 | UBE2N | ubiquitin-conjugating enzyme E2N | 9918 | 0.15 | 
| chr1_235467150_235467301 | 1.37 | GGPS1 | geranylgeranyl diphosphate synthase 1 | 23440 | 0.17 | 
| chr2_198815860_198816011 | 1.30 | PLCL1 | phospholipase C-like 1 | 132601 | 0.05 | 
| chr3_156383415_156383566 | 1.27 | TIPARP-AS1 | TIPARP antisense RNA 1 | 7169 | 0.23 | 
| chr3_66352404_66352729 | 1.23 | ENSG00000206759 | . | 8922 | 0.23 | 
| chr16_53550996_53551207 | 1.19 | AKTIP | AKT interacting protein | 12778 | 0.21 | 
| chr1_100908166_100908711 | 1.17 | RP5-837M10.4 |  | 43115 | 0.14 | 
| chr11_118232493_118232867 | 1.15 | UBE4A | ubiquitination factor E4A | 2321 | 0.18 | 
| chr20_43543317_43543468 | 1.14 | PABPC1L | poly(A) binding protein, cytoplasmic 1-like | 4607 | 0.17 | 
| chr6_16421963_16422331 | 1.11 | ENSG00000265642 | . | 6607 | 0.32 | 
| chr11_128348841_128349039 | 1.11 | ETS1 | v-ets avian erythroblastosis virus E26 oncogene homolog 1 | 26349 | 0.22 | 
| chr7_76823195_76823489 | 1.09 | FGL2 | fibrinogen-like 2 | 5801 | 0.24 | 
| chr2_175353689_175353840 | 1.07 | GPR155 | G protein-coupled receptor 155 | 1942 | 0.34 | 
| chr21_47308624_47308775 | 1.06 | PCBP3 | poly(rC) binding protein 3 | 5092 | 0.22 | 
| chr3_61559181_61559332 | 1.05 | PTPRG | protein tyrosine phosphatase, receptor type, G | 11671 | 0.31 | 
| chr10_17274804_17274955 | 1.04 | RP11-124N14.3 |  | 1953 | 0.24 | 
| chr17_80083513_80083920 | 1.03 | CCDC57 | coiled-coil domain containing 57 | 2716 | 0.14 | 
| chr21_38784198_38784491 | 1.02 | DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 6863 | 0.24 | 
| chr1_101394347_101394839 | 1.02 | SLC30A7 | solute carrier family 30 (zinc transporter), member 7 | 32783 | 0.12 | 
| chr16_53526439_53526844 | 1.01 | AKTIP | AKT interacting protein | 7600 | 0.2 | 
| chr2_158288596_158288794 | 1.01 | CYTIP | cytohesin 1 interacting protein | 7231 | 0.23 | 
| chr4_100766772_100766923 | 1.00 | DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 28844 | 0.18 | 
| chr9_110053291_110053442 | 0.99 | RAD23B | RAD23 homolog B (S. cerevisiae) | 6390 | 0.31 | 
| chr5_49713436_49713587 | 0.98 | EMB | embigin | 11050 | 0.32 | 
| chr2_12402850_12403151 | 0.98 | ENSG00000264089 | . | 63744 | 0.14 | 
| chr2_198102304_198102531 | 0.98 | ANKRD44 | ankyrin repeat domain 44 | 39655 | 0.14 | 
| chr5_114873972_114874300 | 0.98 | FEM1C | fem-1 homolog c (C. elegans) | 6455 | 0.23 | 
| chr11_64853439_64853590 | 0.98 | ZFPL1 | zinc finger protein-like 1 | 889 | 0.27 | 
| chr14_62001455_62001606 | 0.97 | RP11-47I22.4 |  | 5684 | 0.21 | 
| chr2_238884044_238884195 | 0.97 | UBE2F | ubiquitin-conjugating enzyme E2F (putative) | 2382 | 0.32 | 
| chrX_78205440_78205812 | 0.96 | P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 4708 | 0.36 | 
| chr22_23131538_23131788 | 0.95 | ENSG00000207833 | . | 3314 | 0.06 | 
| chr18_67615445_67615629 | 0.95 | CD226 | CD226 molecule | 448 | 0.89 | 
| chr6_112182017_112182276 | 0.95 | FYN | FYN oncogene related to SRC, FGR, YES | 2560 | 0.4 | 
| chr2_205943204_205943355 | 0.94 | PARD3B | par-3 family cell polarity regulator beta | 532556 | 0.0 | 
| chr18_59862387_59862538 | 0.94 | KIAA1468 | KIAA1468 | 7938 | 0.2 | 
| chr1_29388426_29388715 | 0.94 | TMEM200B | transmembrane protein 200B | 60443 | 0.1 | 
| chr2_171984427_171984578 | 0.94 | ENSG00000238567 | . | 18338 | 0.22 | 
| chr5_96308545_96308896 | 0.94 | ENSG00000200884 | . | 10259 | 0.19 | 
| chr1_111209754_111210001 | 0.93 | KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 7778 | 0.18 | 
| chr4_140002475_140002626 | 0.93 | ELF2 | E74-like factor 2 (ets domain transcription factor) | 2794 | 0.22 | 
| chr11_95949552_95949826 | 0.92 | ENSG00000266192 | . | 124913 | 0.05 | 
| chr14_64116714_64117321 | 0.92 | ENSG00000200693 | . | 1200 | 0.38 | 
| chr5_142608359_142608828 | 0.91 | ARHGAP26 | Rho GTPase activating protein 26 | 21828 | 0.23 | 
| chr14_61836268_61836532 | 0.91 | PRKCH | protein kinase C, eta | 8608 | 0.24 | 
| chr7_150381547_150381741 | 0.91 | GIMAP2 | GTPase, IMAP family member 2 | 1144 | 0.47 | 
| chr12_92405189_92405340 | 0.90 | C12orf79 | chromosome 12 open reading frame 79 | 125533 | 0.05 | 
| chr22_40642780_40643209 | 0.90 | TNRC6B | trinucleotide repeat containing 6B | 18013 | 0.23 | 
| chr3_108550085_108550421 | 0.90 | TRAT1 | T cell receptor associated transmembrane adaptor 1 | 8634 | 0.27 | 
| chr10_120855557_120855892 | 0.90 | FAM45A | family with sequence similarity 45, member A | 7876 | 0.14 | 
| chr3_195252228_195252379 | 0.90 | ENSG00000252620 | . | 2284 | 0.26 | 
| chr2_197014969_197015443 | 0.89 | RP11-347P5.1 |  | 781 | 0.66 | 
| chr4_178257933_178258084 | 0.89 | RP11-376O6.2 |  | 20178 | 0.19 | 
| chr2_109581254_109581575 | 0.88 | EDAR | ectodysplasin A receptor | 24311 | 0.24 | 
| chr5_145593023_145593246 | 0.88 | RBM27 | RNA binding motif protein 27 | 9971 | 0.19 | 
| chr3_127348995_127349623 | 0.88 | PODXL2 | podocalyxin-like 2 | 1285 | 0.41 | 
| chr12_14583713_14583864 | 0.88 | ATF7IP | activating transcription factor 7 interacting protein | 7093 | 0.25 | 
| chr15_86045523_86045694 | 0.88 | AKAP13 | A kinase (PRKA) anchor protein 13 | 41663 | 0.15 | 
| chr11_48020234_48020641 | 0.87 | AC103828.1 |  | 16970 | 0.19 | 
| chr20_62894793_62894944 | 0.87 | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 | 1997 | 0.4 | 
| chr19_42049849_42050118 | 0.87 | CEACAM21 | carcinoembryonic antigen-related cell adhesion molecule 21 | 5903 | 0.18 | 
| chr6_24891820_24891971 | 0.87 | FAM65B | family with sequence similarity 65, member B | 14312 | 0.21 | 
| chr8_90802794_90803092 | 0.86 | RIPK2 | receptor-interacting serine-threonine kinase 2 | 32881 | 0.22 | 
| chr1_144503526_144503765 | 0.86 | RP11-640M9.1 |  | 11763 | 0.18 | 
| chr3_43384422_43384573 | 0.86 | RP11-188P20.3 |  | 4638 | 0.2 | 
| chr2_144282251_144282402 | 0.86 | AC096558.1 |  | 43968 | 0.15 | 
| chr2_37888259_37888565 | 0.85 | CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 10922 | 0.27 | 
| chr10_27078179_27078330 | 0.85 | ENSG00000223027 | . | 308 | 0.85 | 
| chr13_100309436_100309662 | 0.85 | ENSG00000263615 | . | 14236 | 0.18 | 
| chr6_118929799_118929950 | 0.85 | CEP85L | centrosomal protein 85kDa-like | 43146 | 0.18 | 
| chr16_7206249_7206400 | 0.84 | ENSG00000212189 | . | 152211 | 0.04 | 
| chr6_64367047_64367198 | 0.84 | PHF3 | PHD finger protein 3 | 10691 | 0.27 | 
| chr10_112651307_112651546 | 0.84 | ENSG00000265827 | . | 6422 | 0.14 | 
| chr1_144323251_144323522 | 0.84 | ENSG00000207106 | . | 12010 | 0.19 | 
| chr4_48765500_48765651 | 0.84 | FRYL | FRY-like | 16690 | 0.22 | 
| chr1_240740736_240741022 | 0.83 | RP11-467I20.6 |  | 13169 | 0.2 | 
| chr17_74195218_74195369 | 0.83 | RNF157 | ring finger protein 157 | 32130 | 0.11 | 
| chr4_100886989_100887255 | 0.83 | RP11-15B17.1 |  | 15442 | 0.17 | 
| chr8_19415375_19415526 | 0.83 | CSGALNACT1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 43926 | 0.21 | 
| chr15_57241711_57241862 | 0.83 | ENSG00000222586 | . | 16809 | 0.2 | 
| chr15_40475765_40476212 | 0.83 | BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | 22720 | 0.12 | 
| chr12_21605567_21605718 | 0.83 | PYROXD1 | pyridine nucleotide-disulphide oxidoreductase domain 1 | 14793 | 0.17 | 
| chr9_80341293_80341444 | 0.83 | GNA14 | guanine nucleotide binding protein (G protein), alpha 14 | 78145 | 0.1 | 
| chr1_169672251_169672700 | 0.82 | SELL | selectin L | 8364 | 0.2 | 
| chr3_151922901_151923094 | 0.82 | MBNL1 | muscleblind-like splicing regulator 1 | 62832 | 0.13 | 
| chr3_16552012_16552185 | 0.82 | RFTN1 | raftlin, lipid raft linker 1 | 2313 | 0.4 | 
| chr5_133550277_133550428 | 0.82 | PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 9732 | 0.15 | 
| chr5_156964747_156964971 | 0.82 | AC106801.1 |  | 28113 | 0.14 | 
| chr1_226912382_226912865 | 0.82 | ITPKB | inositol-trisphosphate 3-kinase B | 12536 | 0.22 | 
| chrX_38666948_38667099 | 0.81 | MID1IP1-AS1 | MID1IP1 antisense RNA 1 | 3887 | 0.27 | 
| chr7_7199370_7199645 | 0.81 | C1GALT1 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 | 2942 | 0.26 | 
| chr2_37471099_37471250 | 0.81 | NDUFAF7 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 7 | 12189 | 0.13 | 
| chr7_140752946_140753195 | 0.81 | ENSG00000223212 | . | 1021 | 0.57 | 
| chr12_7502629_7502823 | 0.81 | CD163L1 | CD163 molecule-like 1 | 18840 | 0.19 | 
| chr4_3205185_3205539 | 0.81 | MSANTD1 | Myb/SANT-like DNA-binding domain containing 1 | 40734 | 0.15 | 
| chr2_32160301_32160461 | 0.81 | ENSG00000221326 | . | 15363 | 0.19 | 
| chr1_90125735_90125925 | 0.80 | LRRC8C | leucine rich repeat containing 8 family, member C | 27199 | 0.15 | 
| chr6_160105627_160105778 | 0.80 | SOD2 | superoxide dismutase 2, mitochondrial | 8558 | 0.18 | 
| chr3_188047910_188048061 | 0.80 | LPP | LIM domain containing preferred translocation partner in lipoma | 90333 | 0.09 | 
| chr2_225887301_225887563 | 0.80 | ENSG00000263828 | . | 12175 | 0.25 | 
| chr6_112089486_112089707 | 0.80 | FYN | FYN oncogene related to SRC, FGR, YES | 8476 | 0.28 | 
| chr5_114819511_114819662 | 0.80 | FEM1C | fem-1 homolog c (C. elegans) | 61005 | 0.12 | 
| chr2_161172927_161173078 | 0.80 | ENSG00000252465 | . | 80477 | 0.09 | 
| chr10_65015821_65016016 | 0.80 | JMJD1C | jumonji domain containing 1C | 12908 | 0.26 | 
| chr1_51705341_51705492 | 0.80 | RNF11 | ring finger protein 11 | 3473 | 0.18 | 
| chr16_29869818_29869969 | 0.80 | CDIPT | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | 3122 | 0.1 | 
| chr11_7457612_7457849 | 0.79 | CTD-2516F10.2 |  | 869 | 0.66 | 
| chr20_47430189_47430589 | 0.79 | PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 14031 | 0.26 | 
| chr3_113952777_113952998 | 0.79 | ZNF80 | zinc finger protein 80 | 3538 | 0.21 | 
| chr1_246736426_246736655 | 0.79 | CNST | consortin, connexin sorting protein | 6724 | 0.19 | 
| chr1_59259851_59260002 | 0.79 | JUN | jun proto-oncogene | 10141 | 0.22 | 
| chr1_8209252_8209494 | 0.79 | ENSG00000200975 | . | 57284 | 0.13 | 
| chr13_74435860_74436029 | 0.78 | KLF12 | Kruppel-like factor 12 | 133242 | 0.06 | 
| chr2_238978123_238978536 | 0.78 | SCLY | selenocysteine lyase | 224 | 0.93 | 
| chr10_28835675_28835826 | 0.78 | WAC | WW domain containing adaptor with coiled-coil | 12698 | 0.2 | 
| chr3_108559140_108559291 | 0.78 | TRAT1 | T cell receptor associated transmembrane adaptor 1 | 17596 | 0.24 | 
| chr5_109188443_109188700 | 0.78 | AC011366.3 | Uncharacterized protein | 30312 | 0.24 | 
| chr11_72567970_72568121 | 0.78 | ENSG00000206638 | . | 12650 | 0.15 | 
| chr15_38965016_38965639 | 0.78 | C15orf53 | chromosome 15 open reading frame 53 | 23472 | 0.24 | 
| chr15_91966261_91966815 | 0.78 | SV2B | synaptic vesicle glycoprotein 2B | 197438 | 0.03 | 
| chr20_47556435_47556586 | 0.77 | ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | 18083 | 0.24 | 
| chr17_57078918_57079286 | 0.77 | TRIM37 | tripartite motif containing 37 | 10666 | 0.15 | 
| chr1_89743910_89744153 | 0.77 | GBP5 | guanylate binding protein 5 | 5487 | 0.21 | 
| chr5_80260555_80260706 | 0.77 | CTC-459I6.1 |  | 3904 | 0.26 | 
| chr13_31201174_31201431 | 0.77 | USPL1 | ubiquitin specific peptidase like 1 | 9382 | 0.23 | 
| chr13_75897174_75897393 | 0.77 | TBC1D4 | TBC1 domain family, member 4 | 18384 | 0.24 | 
| chr2_99120667_99121116 | 0.77 | INPP4A | inositol polyphosphate-4-phosphatase, type I, 107kDa | 15621 | 0.23 | 
| chr1_67615233_67615384 | 0.77 | C1orf141 | chromosome 1 open reading frame 141 | 14648 | 0.16 | 
| chr2_42482692_42482843 | 0.77 | EML4 | echinoderm microtubule associated protein like 4 | 45626 | 0.16 | 
| chr16_67619870_67620021 | 0.76 | CTCF | CCCTC-binding factor (zinc finger protein) | 23635 | 0.08 | 
| chr12_42090922_42091073 | 0.76 | ENSG00000252364 | . | 38519 | 0.22 | 
| chr7_104628559_104628710 | 0.76 | ENSG00000251911 | . | 16900 | 0.15 | 
| chr1_231596385_231596708 | 0.76 | EGLN1 | egl-9 family hypoxia-inducible factor 1 | 35756 | 0.16 | 
| chrX_123153814_123153965 | 0.76 | STAG2 | stromal antigen 2 | 56869 | 0.14 | 
| chr22_30675082_30675729 | 0.75 | GATSL3 | GATS protein-like 3 | 10191 | 0.09 | 
| chr5_110564408_110564849 | 0.75 | CAMK4 | calcium/calmodulin-dependent protein kinase IV | 4844 | 0.26 | 
| chr13_74701587_74701980 | 0.75 | KLF12 | Kruppel-like factor 12 | 6611 | 0.34 | 
| chr14_21705745_21705909 | 0.75 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 6246 | 0.19 | 
| chr4_108992806_108993006 | 0.75 | HADH | hydroxyacyl-CoA dehydrogenase | 67115 | 0.1 | 
| chrX_44778038_44778208 | 0.75 | ENSG00000252113 | . | 33372 | 0.18 | 
| chr15_60864986_60865137 | 0.75 | RORA | RAR-related orphan receptor A | 19679 | 0.19 | 
| chr6_52245245_52245624 | 0.75 | PAQR8 | progestin and adipoQ receptor family member VIII | 18190 | 0.21 | 
| chr16_66596968_66597430 | 0.75 | CKLF-CMTM1 | CKLF-CMTM1 readthrough | 168 | 0.89 | 
| chr10_65177467_65177618 | 0.75 | ENSG00000221063 | . | 44734 | 0.14 | 
| chr1_100893242_100893421 | 0.75 | ENSG00000216067 | . | 49000 | 0.12 | 
| chr4_109061052_109061203 | 0.75 | LEF1 | lymphoid enhancer-binding factor 1 | 26330 | 0.2 | 
| chr8_66672869_66673020 | 0.75 | PDE7A | phosphodiesterase 7A | 28375 | 0.19 | 
| chr1_174923612_174923763 | 0.75 | RP1-102G20.5 |  | 289 | 0.89 | 
| chr7_114565894_114566047 | 0.75 | MDFIC | MyoD family inhibitor domain containing | 2839 | 0.42 | 
| chr2_102525718_102525869 | 0.74 | FLJ20373 |  | 16838 | 0.23 | 
| chr3_178070915_178071066 | 0.74 | LINC01014 | long intergenic non-protein coding RNA 1014 | 65999 | 0.12 | 
| chr13_99104793_99104944 | 0.74 | STK24 | serine/threonine kinase 24 | 11171 | 0.18 | 
| chr5_118729383_118729534 | 0.74 | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 37728 | 0.14 | 
| chr7_114857333_114857484 | 0.74 | ENSG00000199764 | . | 9358 | 0.33 | 
| chr11_14601295_14601599 | 0.74 | PSMA1 | proteasome (prosome, macropain) subunit, alpha type, 1 | 59205 | 0.12 | 
| chr2_97006901_97007068 | 0.74 | NCAPH | non-SMC condensin I complex, subunit H | 5428 | 0.16 | 
| chr10_73863981_73864132 | 0.74 | SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 15266 | 0.2 | 
| chr6_112116750_112116951 | 0.73 | FYN | FYN oncogene related to SRC, FGR, YES | 1735 | 0.49 | 
| chr5_39168938_39169130 | 0.73 | FYB | FYN binding protein | 34095 | 0.2 | 
| chr13_100163013_100163346 | 0.73 | TM9SF2 | transmembrane 9 superfamily member 2 | 9508 | 0.17 | 
| chr14_56739134_56739285 | 0.73 | PELI2 | pellino E3 ubiquitin protein ligase family member 2 | 153382 | 0.04 | 
| chr9_96218539_96218814 | 0.73 | FAM120AOS | family with sequence similarity 120A opposite strand | 2802 | 0.19 | 
| chr10_14610710_14611033 | 0.73 | FAM107B | family with sequence similarity 107, member B | 3158 | 0.32 | 
| chr3_113936392_113936595 | 0.72 | RP11-553L6.2 |  | 3255 | 0.22 | 
| chr15_41735495_41735646 | 0.72 | ENSG00000200407 | . | 5472 | 0.16 | 
| chr2_68692820_68692990 | 0.72 | FBXO48 | F-box protein 48 | 1485 | 0.36 | 
| chr1_9789105_9789546 | 0.72 | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | 11198 | 0.17 | 
| chr7_7887496_7887647 | 0.72 | ENSG00000201747 | . | 58579 | 0.12 | 
| chr18_60956187_60956462 | 0.72 | RP11-28F1.2 |  | 24991 | 0.16 | 
| chr18_47313307_47313536 | 0.72 | ACAA2 | acetyl-CoA acyltransferase 2 | 24480 | 0.13 | 
| chr3_45739129_45739318 | 0.72 | SACM1L | SAC1 suppressor of actin mutations 1-like (yeast) | 8272 | 0.18 | 
| chr6_24780147_24780298 | 0.72 | GMNN | geminin, DNA replication inhibitor | 3128 | 0.2 | 
| chr2_42456564_42456839 | 0.72 | AC083949.1 |  | 59260 | 0.12 | 
| chr11_108102757_108102978 | 0.71 | ENSG00000206967 | . | 2536 | 0.23 | 
| chr5_118725608_118725842 | 0.71 | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 33995 | 0.15 | 
| chr17_75996475_75996626 | 0.71 | TNRC6C | trinucleotide repeat containing 6C | 3699 | 0.25 | 
| chr2_183901743_183901960 | 0.71 | NCKAP1 | NCK-associated protein 1 | 1349 | 0.4 | 
| chr2_12901157_12901451 | 0.71 | ENSG00000264370 | . | 23811 | 0.24 | 
| chr13_41578402_41578595 | 0.71 | ELF1 | E74-like factor 1 (ets domain transcription factor) | 14952 | 0.19 | 
| chr22_36046536_36046687 | 0.71 | APOL6 | apolipoprotein L, 6 | 2169 | 0.29 | 
| chr12_40023474_40023652 | 0.71 | C12orf40 | chromosome 12 open reading frame 40 | 3578 | 0.29 | 
| chr17_4078692_4078901 | 0.71 | ENSG00000251812 | . | 10825 | 0.11 | 
| chr6_140246597_140246748 | 0.71 | ENSG00000252107 | . | 233159 | 0.02 | 
| chr14_71463467_71463618 | 0.71 | PCNX | pecanex homolog (Drosophila) | 16206 | 0.29 | 
| chr13_111526304_111526455 | 0.71 | LINC00346 | long intergenic non-protein coding RNA 346 | 4217 | 0.23 | 
| chr13_115044765_115045188 | 0.71 | UPF3A | UPF3 regulator of nonsense transcripts homolog A (yeast) | 2083 | 0.26 | 
| chr1_97229482_97229633 | 0.70 | PTBP2 | polypyrimidine tract binding protein 2 | 41284 | 0.18 | 
| chr4_84271786_84272009 | 0.70 | HPSE | heparanase | 15591 | 0.23 | 
| chr10_95273033_95273184 | 0.70 | ENSG00000212396 | . | 2671 | 0.24 | 
| chr7_151841320_151841471 | 0.70 | KMT2C | lysine (K)-specific methyltransferase 2C | 1511 | 0.41 | 
| chr8_134627515_134627799 | 0.70 | ENSG00000212273 | . | 29311 | 0.22 | 
| chr9_99327216_99327367 | 0.70 | CDC14B | cell division cycle 14B | 1821 | 0.45 | 
| chr2_234317819_234318081 | 0.70 | DGKD | diacylglycerol kinase, delta 130kDa | 21150 | 0.16 | 
| chr9_110032208_110032359 | 0.70 | RAD23B | RAD23 homolog B (S. cerevisiae) | 13135 | 0.29 | 
| chr10_33406261_33406412 | 0.70 | ENSG00000263576 | . | 18772 | 0.22 | 
| chr1_90121517_90121670 | 0.70 | LRRC8C | leucine rich repeat containing 8 family, member C | 22962 | 0.16 | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.6 | 1.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) | 
| 0.6 | 2.5 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) | 
| 0.6 | 3.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) | 
| 0.6 | 2.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) | 
| 0.5 | 3.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) | 
| 0.5 | 2.4 | GO:0002517 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) | 
| 0.5 | 1.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) | 
| 0.4 | 1.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) | 
| 0.4 | 1.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) | 
| 0.4 | 1.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) | 
| 0.4 | 1.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) | 
| 0.4 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) | 
| 0.4 | 0.7 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) | 
| 0.4 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) | 
| 0.4 | 3.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) | 
| 0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) | 
| 0.3 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) | 
| 0.3 | 2.3 | GO:0006198 | cAMP catabolic process(GO:0006198) | 
| 0.3 | 0.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) | 
| 0.3 | 0.6 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) | 
| 0.3 | 1.8 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) | 
| 0.3 | 1.4 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) | 
| 0.3 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) | 
| 0.3 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) | 
| 0.3 | 2.2 | GO:0006491 | N-glycan processing(GO:0006491) | 
| 0.3 | 2.2 | GO:0002834 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) | 
| 0.3 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) | 
| 0.3 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) | 
| 0.3 | 0.8 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) | 
| 0.2 | 6.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) | 
| 0.2 | 1.4 | GO:0043368 | positive T cell selection(GO:0043368) | 
| 0.2 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) | 
| 0.2 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) | 
| 0.2 | 0.4 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) | 
| 0.2 | 0.6 | GO:0060242 | contact inhibition(GO:0060242) | 
| 0.2 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) | 
| 0.2 | 0.6 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) | 
| 0.2 | 0.4 | GO:0034776 | response to histamine(GO:0034776) | 
| 0.2 | 0.4 | GO:0048541 | Peyer's patch development(GO:0048541) | 
| 0.2 | 1.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) | 
| 0.2 | 0.9 | GO:0022614 | membrane to membrane docking(GO:0022614) | 
| 0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) | 
| 0.2 | 0.2 | GO:0002335 | mature B cell differentiation(GO:0002335) | 
| 0.2 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) | 
| 0.2 | 0.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) | 
| 0.2 | 1.3 | GO:0007172 | signal complex assembly(GO:0007172) | 
| 0.2 | 0.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) | 
| 0.2 | 0.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) | 
| 0.2 | 0.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) | 
| 0.2 | 0.5 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) | 
| 0.2 | 0.9 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) | 
| 0.2 | 0.5 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) | 
| 0.2 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) | 
| 0.2 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) | 
| 0.2 | 0.8 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) | 
| 0.2 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) | 
| 0.2 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) | 
| 0.2 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) | 
| 0.2 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) | 
| 0.2 | 1.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) | 
| 0.2 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) | 
| 0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) | 
| 0.2 | 0.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) | 
| 0.2 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) | 
| 0.2 | 0.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) | 
| 0.2 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) | 
| 0.2 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) | 
| 0.2 | 0.5 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) | 
| 0.1 | 1.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) | 
| 0.1 | 0.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) | 
| 0.1 | 1.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) | 
| 0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) | 
| 0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) | 
| 0.1 | 0.9 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) | 
| 0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) | 
| 0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) | 
| 0.1 | 0.5 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) | 
| 0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) | 
| 0.1 | 1.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) | 
| 0.1 | 0.8 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) | 
| 0.1 | 0.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) | 
| 0.1 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) | 
| 0.1 | 1.0 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) | 
| 0.1 | 0.5 | GO:0046666 | retinal cell programmed cell death(GO:0046666) | 
| 0.1 | 0.4 | GO:0014889 | muscle atrophy(GO:0014889) | 
| 0.1 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) | 
| 0.1 | 0.5 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) | 
| 0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) | 
| 0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) | 
| 0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) | 
| 0.1 | 2.2 | GO:0046847 | filopodium assembly(GO:0046847) | 
| 0.1 | 0.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) | 
| 0.1 | 1.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) | 
| 0.1 | 0.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) | 
| 0.1 | 0.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) | 
| 0.1 | 0.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) | 
| 0.1 | 0.6 | GO:0051383 | kinetochore organization(GO:0051383) | 
| 0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) | 
| 0.1 | 0.7 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) | 
| 0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) | 
| 0.1 | 0.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) | 
| 0.1 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) | 
| 0.1 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) | 
| 0.1 | 0.4 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) | 
| 0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) | 
| 0.1 | 1.7 | GO:0016578 | histone deubiquitination(GO:0016578) | 
| 0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) | 
| 0.1 | 7.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) | 
| 0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) | 
| 0.1 | 1.1 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) | 
| 0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) | 
| 0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) | 
| 0.1 | 0.4 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) | 
| 0.1 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) | 
| 0.1 | 0.3 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) | 
| 0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) | 
| 0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) | 
| 0.1 | 0.5 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) | 
| 0.1 | 0.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) | 
| 0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) | 
| 0.1 | 2.3 | GO:0046677 | response to antibiotic(GO:0046677) | 
| 0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) | 
| 0.1 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) | 
| 0.1 | 0.1 | GO:0071803 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) | 
| 0.1 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) | 
| 0.1 | 0.2 | GO:0052308 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) | 
| 0.1 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) | 
| 0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) | 
| 0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) | 
| 0.1 | 0.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) | 
| 0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) | 
| 0.1 | 1.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) | 
| 0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) | 
| 0.1 | 0.3 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) | 
| 0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) | 
| 0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) | 
| 0.1 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) | 
| 0.1 | 0.1 | GO:0052556 | positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) | 
| 0.1 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) | 
| 0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) | 
| 0.1 | 0.6 | GO:0045822 | negative regulation of heart contraction(GO:0045822) | 
| 0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) | 
| 0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) | 
| 0.1 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) | 
| 0.1 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) | 
| 0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) | 
| 0.1 | 0.3 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) | 
| 0.1 | 0.8 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) | 
| 0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) | 
| 0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) | 
| 0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) | 
| 0.1 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) | 
| 0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) | 
| 0.1 | 0.4 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) | 
| 0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) | 
| 0.1 | 0.2 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) | 
| 0.1 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) | 
| 0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) | 
| 0.1 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) | 
| 0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) | 
| 0.1 | 2.0 | GO:0006611 | protein export from nucleus(GO:0006611) | 
| 0.1 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) | 
| 0.1 | 0.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) | 
| 0.1 | 2.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) | 
| 0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) | 
| 0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) | 
| 0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) | 
| 0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) | 
| 0.1 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) | 
| 0.1 | 0.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) | 
| 0.1 | 0.1 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) | 
| 0.1 | 0.8 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) | 
| 0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) | 
| 0.1 | 0.3 | GO:0031297 | replication fork processing(GO:0031297) | 
| 0.1 | 0.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) | 
| 0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) | 
| 0.1 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) | 
| 0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) | 
| 0.1 | 0.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) | 
| 0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) | 
| 0.1 | 0.1 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) | 
| 0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) | 
| 0.1 | 0.3 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) | 
| 0.1 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) | 
| 0.1 | 0.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) | 
| 0.1 | 0.1 | GO:0071504 | cellular response to heparin(GO:0071504) | 
| 0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) | 
| 0.1 | 0.2 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) | 
| 0.1 | 0.6 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) | 
| 0.1 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) | 
| 0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) | 
| 0.1 | 0.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) | 
| 0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) | 
| 0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) | 
| 0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) | 
| 0.1 | 0.2 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) | 
| 0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) | 
| 0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) | 
| 0.1 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) | 
| 0.1 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) | 
| 0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) | 
| 0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) | 
| 0.1 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) | 
| 0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) | 
| 0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) | 
| 0.1 | 0.6 | GO:0000305 | response to oxygen radical(GO:0000305) | 
| 0.1 | 0.2 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) | 
| 0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) | 
| 0.1 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) | 
| 0.1 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) | 
| 0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) | 
| 0.1 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) | 
| 0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) | 
| 0.1 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) | 
| 0.1 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) | 
| 0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) | 
| 0.1 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) | 
| 0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) | 
| 0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) | 
| 0.1 | 0.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) | 
| 0.1 | 0.5 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) | 
| 0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) | 
| 0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) | 
| 0.1 | 0.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) | 
| 0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) | 
| 0.1 | 0.4 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) | 
| 0.1 | 1.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) | 
| 0.1 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) | 
| 0.1 | 0.2 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) | 
| 0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) | 
| 0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) | 
| 0.1 | 1.0 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) | 
| 0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) | 
| 0.1 | 1.5 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) | 
| 0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) | 
| 0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) | 
| 0.1 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) | 
| 0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) | 
| 0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) | 
| 0.1 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) | 
| 0.1 | 0.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) | 
| 0.1 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) | 
| 0.1 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) | 
| 0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) | 
| 0.1 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) | 
| 0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) | 
| 0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) | 
| 0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) | 
| 0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) | 
| 0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) | 
| 0.1 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) | 
| 0.1 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) | 
| 0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) | 
| 0.1 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) | 
| 0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) | 
| 0.1 | 3.0 | GO:0008360 | regulation of cell shape(GO:0008360) | 
| 0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) | 
| 0.1 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) | 
| 0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) | 
| 0.1 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) | 
| 0.1 | 0.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) | 
| 0.1 | 0.5 | GO:0090501 | mRNA cleavage(GO:0006379) RNA phosphodiester bond hydrolysis(GO:0090501) | 
| 0.1 | 0.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) | 
| 0.1 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) | 
| 0.1 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) | 
| 0.1 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) | 
| 0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) | 
| 0.1 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) | 
| 0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) | 
| 0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) | 
| 0.0 | 0.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) | 
| 0.0 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) | 
| 0.0 | 0.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) | 
| 0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) | 
| 0.0 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) | 
| 0.0 | 0.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) | 
| 0.0 | 0.1 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) | 
| 0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) | 
| 0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) | 
| 0.0 | 0.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) | 
| 0.0 | 0.1 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) | 
| 0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) | 
| 0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) | 
| 0.0 | 0.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) | 
| 0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) | 
| 0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) | 
| 0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) | 
| 0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) | 
| 0.0 | 0.2 | GO:0045123 | cellular extravasation(GO:0045123) | 
| 0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) | 
| 0.0 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) | 
| 0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) | 
| 0.0 | 0.0 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) | 
| 0.0 | 0.2 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) | 
| 0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) | 
| 0.0 | 0.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) | 
| 0.0 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) | 
| 0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) | 
| 0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) | 
| 0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) | 
| 0.0 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) | 
| 0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) | 
| 0.0 | 0.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) | 
| 0.0 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) | 
| 0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) | 
| 0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) | 
| 0.0 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) | 
| 0.0 | 1.6 | GO:0006405 | RNA export from nucleus(GO:0006405) | 
| 0.0 | 0.3 | GO:0048535 | lymph node development(GO:0048535) | 
| 0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) | 
| 0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) | 
| 0.0 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) | 
| 0.0 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) | 
| 0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) | 
| 0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) | 
| 0.0 | 0.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) | 
| 0.0 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) | 
| 0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) | 
| 0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) | 
| 0.0 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) | 
| 0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) | 
| 0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) | 
| 0.0 | 0.4 | GO:0001556 | oocyte maturation(GO:0001556) | 
| 0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) | 
| 0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) | 
| 0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) | 
| 0.0 | 1.6 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) | 
| 0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) | 
| 0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) | 
| 0.0 | 0.1 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) | 
| 0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) | 
| 0.0 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) | 
| 0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) | 
| 0.0 | 0.5 | GO:0008210 | estrogen metabolic process(GO:0008210) | 
| 0.0 | 0.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) | 
| 0.0 | 0.1 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) | 
| 0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) | 
| 0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) | 
| 0.0 | 0.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) | 
| 0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) | 
| 0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) | 
| 0.0 | 0.0 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) | 
| 0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) | 
| 0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) | 
| 0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) | 
| 0.0 | 0.4 | GO:0042255 | ribosome assembly(GO:0042255) | 
| 0.0 | 0.1 | GO:0045007 | depurination(GO:0045007) | 
| 0.0 | 0.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) | 
| 0.0 | 0.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) | 
| 0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) | 
| 0.0 | 0.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) | 
| 0.0 | 0.2 | GO:0001885 | endothelial cell development(GO:0001885) | 
| 0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) | 
| 0.0 | 0.4 | GO:0001510 | RNA methylation(GO:0001510) | 
| 0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) | 
| 0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) | 
| 0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) | 
| 0.0 | 0.4 | GO:0043967 | histone H4 acetylation(GO:0043967) | 
| 0.0 | 0.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) | 
| 0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) | 
| 0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) | 
| 0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) | 
| 0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) | 
| 0.0 | 1.0 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) | 
| 0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) | 
| 0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) | 
| 0.0 | 0.1 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) | 
| 0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) | 
| 0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) | 
| 0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) | 
| 0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) | 
| 0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) | 
| 0.0 | 0.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) | 
| 0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) | 
| 0.0 | 0.6 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) | 
| 0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) | 
| 0.0 | 0.1 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) | 
| 0.0 | 0.2 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) | 
| 0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) | 
| 0.0 | 0.1 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) | 
| 0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) | 
| 0.0 | 0.0 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) | 
| 0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) | 
| 0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) | 
| 0.0 | 0.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) | 
| 0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) | 
| 0.0 | 0.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) | 
| 0.0 | 1.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) | 
| 0.0 | 0.2 | GO:0051303 | chromosome localization(GO:0050000) establishment of chromosome localization(GO:0051303) | 
| 0.0 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) | 
| 0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) | 
| 0.0 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) | 
| 0.0 | 0.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) | 
| 0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) | 
| 0.0 | 0.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) | 
| 0.0 | 0.8 | GO:0016579 | protein deubiquitination(GO:0016579) | 
| 0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) | 
| 0.0 | 0.1 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) | 
| 0.0 | 0.7 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) | 
| 0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) | 
| 0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) | 
| 0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) | 
| 0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) | 
| 0.0 | 0.1 | GO:0060666 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) | 
| 0.0 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) | 
| 0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) | 
| 0.0 | 0.2 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) | 
| 0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) | 
| 0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) | 
| 0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) | 
| 0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) | 
| 0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) | 
| 0.0 | 0.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) | 
| 0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) | 
| 0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) | 
| 0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) | 
| 0.0 | 0.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) | 
| 0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) | 
| 0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) | 
| 0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) | 
| 0.0 | 0.1 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) | 
| 0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) | 
| 0.0 | 0.1 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) | 
| 0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) | 
| 0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) | 
| 0.0 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) | 
| 0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) | 
| 0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) | 
| 0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) | 
| 0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) | 
| 0.0 | 0.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) | 
| 0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) | 
| 0.0 | 0.0 | GO:0071732 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) | 
| 0.0 | 0.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) | 
| 0.0 | 0.6 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) | 
| 0.0 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) | 
| 0.0 | 0.0 | GO:0060463 | lateral mesoderm development(GO:0048368) lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) | 
| 0.0 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) | 
| 0.0 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) | 
| 0.0 | 0.1 | GO:0014741 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) | 
| 0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) | 
| 0.0 | 0.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) | 
| 0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) | 
| 0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) | 
| 0.0 | 0.1 | GO:0060479 | lung cell differentiation(GO:0060479) | 
| 0.0 | 0.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) | 
| 0.0 | 0.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) | 
| 0.0 | 0.0 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) | 
| 0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) | 
| 0.0 | 0.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) | 
| 0.0 | 0.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) | 
| 0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) | 
| 0.0 | 0.0 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) | 
| 0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) | 
| 0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) | 
| 0.0 | 0.0 | GO:0033088 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) negative regulation of thymocyte aggregation(GO:2000399) | 
| 0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) | 
| 0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) | 
| 0.0 | 0.4 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) | 
| 0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) | 
| 0.0 | 2.3 | GO:0043087 | regulation of GTPase activity(GO:0043087) | 
| 0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) | 
| 0.0 | 0.1 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) | 
| 0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) | 
| 0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) | 
| 0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) | 
| 0.0 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) | 
| 0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) | 
| 0.0 | 0.0 | GO:0070741 | response to interleukin-6(GO:0070741) | 
| 0.0 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) | 
| 0.0 | 0.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) | 
| 0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) | 
| 0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) | 
| 0.0 | 0.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) | 
| 0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) | 
| 0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) | 
| 0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) | 
| 0.0 | 0.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) | 
| 0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) | 
| 0.0 | 0.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) | 
| 0.0 | 0.1 | GO:0071333 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) | 
| 0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) | 
| 0.0 | 0.0 | GO:0014805 | smooth muscle adaptation(GO:0014805) | 
| 0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) | 
| 0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) | 
| 0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) | 
| 0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) | 
| 0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) | 
| 0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) | 
| 0.0 | 0.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) | 
| 0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) | 
| 0.0 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) | 
| 0.0 | 0.0 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) | 
| 0.0 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) | 
| 0.0 | 0.1 | GO:0035751 | vacuolar acidification(GO:0007035) lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) | 
| 0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) | 
| 0.0 | 0.1 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) | 
| 0.0 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) | 
| 0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) | 
| 0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) | 
| 0.0 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) | 
| 0.0 | 0.0 | GO:0052255 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) | 
| 0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) | 
| 0.0 | 0.3 | GO:0021549 | cerebellum development(GO:0021549) | 
| 0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) | 
| 0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) | 
| 0.0 | 0.8 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) | 
| 0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) | 
| 0.0 | 0.0 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) | 
| 0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) | 
| 0.0 | 0.0 | GO:0060292 | long term synaptic depression(GO:0060292) | 
| 0.0 | 0.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) | 
| 0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) | 
| 0.0 | 0.0 | GO:0090398 | cellular senescence(GO:0090398) | 
| 0.0 | 0.2 | GO:0051225 | spindle assembly(GO:0051225) | 
| 0.0 | 0.0 | GO:0002920 | regulation of humoral immune response(GO:0002920) | 
| 0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) | 
| 0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) | 
| 0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) | 
| 0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) | 
| 0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) | 
| 0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) | 
| 0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) | 
| 0.0 | 0.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) | 
| 0.0 | 0.0 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) | 
| 0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) | 
| 0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) | 
| 0.0 | 0.0 | GO:0009988 | cell-cell recognition(GO:0009988) | 
| 0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) | 
| 0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) | 
| 0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) | 
| 0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) | 
| 0.0 | 0.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) | 
| 0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) | 
| 0.0 | 0.6 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) | 
| 0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) | 
| 0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) | 
| 0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) | 
| 0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) | 
| 0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) | 
| 0.0 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) | 
| 0.0 | 0.0 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) | 
| 0.0 | 0.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) | 
| 0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) | 
| 0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) | 
| 0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) | 
| 0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) | 
| 0.0 | 0.2 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) | 
| 0.0 | 0.1 | GO:0007052 | mitotic spindle organization(GO:0007052) | 
| 0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) | 
| 0.0 | 0.0 | GO:0022601 | menstrual cycle phase(GO:0022601) | 
| 0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) | 
| 0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) | 
| 0.0 | 0.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) | 
| 0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) | 
| 0.0 | 0.0 | GO:0030279 | negative regulation of ossification(GO:0030279) | 
| 0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) | 
| 0.0 | 0.0 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) | 
| 0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) | 
| 0.0 | 0.0 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) | 
| 0.0 | 0.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) | 
| 0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) | 
| 0.0 | 0.2 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) | 
| 0.0 | 0.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) | 
| 0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) | 
| 0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) | 
| 0.0 | 0.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) | 
| 0.0 | 0.1 | GO:0050777 | negative regulation of immune response(GO:0050777) | 
| 0.0 | 0.0 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) | 
| 0.0 | 0.0 | GO:0033233 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) | 
| 0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) | 
| 0.0 | 0.0 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) | 
| 0.0 | 0.0 | GO:0001743 | optic placode formation(GO:0001743) | 
| 0.0 | 0.0 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) | 
| 0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.4 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) | 
| 0.3 | 3.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) | 
| 0.3 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) | 
| 0.3 | 0.8 | GO:0072487 | MSL complex(GO:0072487) | 
| 0.2 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) | 
| 0.2 | 0.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) | 
| 0.2 | 0.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) | 
| 0.2 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) | 
| 0.2 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) | 
| 0.2 | 1.6 | GO:0001891 | phagocytic cup(GO:0001891) | 
| 0.2 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) | 
| 0.2 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) | 
| 0.2 | 0.6 | GO:0071942 | XPC complex(GO:0071942) | 
| 0.2 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) | 
| 0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) | 
| 0.2 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) | 
| 0.2 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) | 
| 0.2 | 0.6 | GO:0001740 | Barr body(GO:0001740) | 
| 0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) | 
| 0.1 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) | 
| 0.1 | 0.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) | 
| 0.1 | 1.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) | 
| 0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) | 
| 0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) | 
| 0.1 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) | 
| 0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) | 
| 0.1 | 0.6 | GO:0070688 | MLL5-L complex(GO:0070688) | 
| 0.1 | 0.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) | 
| 0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) | 
| 0.1 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) | 
| 0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) | 
| 0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) | 
| 0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) | 
| 0.1 | 0.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) | 
| 0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) | 
| 0.1 | 1.1 | GO:0045120 | pronucleus(GO:0045120) | 
| 0.1 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) | 
| 0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) | 
| 0.1 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) | 
| 0.1 | 0.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) | 
| 0.1 | 3.3 | GO:0030175 | filopodium(GO:0030175) | 
| 0.1 | 0.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) | 
| 0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) | 
| 0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) | 
| 0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) | 
| 0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) | 
| 0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) | 
| 0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) | 
| 0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) | 
| 0.1 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) | 
| 0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) | 
| 0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) | 
| 0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) | 
| 0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) | 
| 0.1 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) | 
| 0.1 | 0.6 | GO:0042598 | obsolete vesicular fraction(GO:0042598) | 
| 0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) | 
| 0.1 | 1.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) | 
| 0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) | 
| 0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) | 
| 0.1 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) | 
| 0.1 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) | 
| 0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) | 
| 0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) | 
| 0.1 | 0.8 | GO:0042627 | chylomicron(GO:0042627) | 
| 0.1 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) | 
| 0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) | 
| 0.1 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) | 
| 0.1 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) | 
| 0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) | 
| 0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) | 
| 0.1 | 0.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) | 
| 0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) | 
| 0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) | 
| 0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) | 
| 0.1 | 0.3 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) | 
| 0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) | 
| 0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) | 
| 0.1 | 0.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) | 
| 0.1 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) | 
| 0.1 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) | 
| 0.1 | 0.7 | GO:0016235 | aggresome(GO:0016235) | 
| 0.1 | 2.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) | 
| 0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) | 
| 0.1 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) | 
| 0.1 | 0.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) | 
| 0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) | 
| 0.1 | 2.6 | GO:0016605 | PML body(GO:0016605) | 
| 0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) | 
| 0.1 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) | 
| 0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) | 
| 0.0 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) | 
| 0.0 | 0.5 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) | 
| 0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) | 
| 0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) | 
| 0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) | 
| 0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) | 
| 0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) | 
| 0.0 | 0.5 | GO:0071203 | WASH complex(GO:0071203) | 
| 0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) | 
| 0.0 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) | 
| 0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) | 
| 0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) | 
| 0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) | 
| 0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) | 
| 0.0 | 0.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) | 
| 0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) | 
| 0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) | 
| 0.0 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) | 
| 0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) | 
| 0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) | 
| 0.0 | 0.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) | 
| 0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) | 
| 0.0 | 0.0 | GO:0032040 | small-subunit processome(GO:0032040) | 
| 0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) | 
| 0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) | 
| 0.0 | 0.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) | 
| 0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) | 
| 0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) | 
| 0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) | 
| 0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) | 
| 0.0 | 3.1 | GO:0019717 | obsolete synaptosome(GO:0019717) | 
| 0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) | 
| 0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) | 
| 0.0 | 0.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) | 
| 0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) | 
| 0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) | 
| 0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) | 
| 0.0 | 0.3 | GO:0032838 | cell projection cytoplasm(GO:0032838) | 
| 0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) | 
| 0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) | 
| 0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) | 
| 0.0 | 1.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) | 
| 0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) | 
| 0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) | 
| 0.0 | 0.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) | 
| 0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) | 
| 0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) | 
| 0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) | 
| 0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) | 
| 0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) | 
| 0.0 | 0.5 | GO:0019861 | obsolete flagellum(GO:0019861) | 
| 0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) | 
| 0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) | 
| 0.0 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) | 
| 0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) | 
| 0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) | 
| 0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) | 
| 0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) | 
| 0.0 | 0.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) | 
| 0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) | 
| 0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) | 
| 0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) | 
| 0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) | 
| 0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) | 
| 0.0 | 0.2 | GO:0098651 | basement membrane collagen trimer(GO:0098651) | 
| 0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) | 
| 0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) | 
| 0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) | 
| 0.0 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) | 
| 0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) | 
| 0.0 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) | 
| 0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) | 
| 0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) | 
| 0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) | 
| 0.0 | 0.0 | GO:0043260 | laminin-11 complex(GO:0043260) | 
| 0.0 | 0.0 | GO:0051233 | spindle midzone(GO:0051233) | 
| 0.0 | 2.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) | 
| 0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) | 
| 0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) | 
| 0.0 | 1.5 | GO:0005769 | early endosome(GO:0005769) | 
| 0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) | 
| 0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) | 
| 0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) | 
| 0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) | 
| 0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) | 
| 0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) | 
| 0.0 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) | 
| 0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) | 
| 0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) | 
| 0.0 | 0.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) | 
| 0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) | 
| 0.0 | 0.2 | GO:0005637 | nuclear inner membrane(GO:0005637) | 
| 0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) | 
| 0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) | 
| 0.0 | 0.7 | GO:0005802 | trans-Golgi network(GO:0005802) | 
| 0.0 | 0.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) | 
| 0.0 | 0.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) | 
| 0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) | 
| 0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) | 
| 0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) | 
| 0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) | 
| 0.0 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) | 
| 0.0 | 7.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) | 
| 0.0 | 0.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) | 
| 0.0 | 0.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) | 
| 0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) | 
| 0.0 | 2.8 | GO:0005768 | endosome(GO:0005768) | 
| 0.0 | 0.0 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) | 
| 0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) | 
| 0.0 | 0.0 | GO:0038201 | TOR complex(GO:0038201) | 
| 0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) | 
| 0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) | 
| 0.0 | 0.0 | GO:0031941 | filamentous actin(GO:0031941) | 
| 0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) | 
| 0.0 | 0.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) | 
| 0.0 | 0.2 | GO:0000794 | condensed nuclear chromosome(GO:0000794) | 
| 0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) | 
| 0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) | 
| 0.0 | 9.1 | GO:0005730 | nucleolus(GO:0005730) | 
| 0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) | 
| 0.0 | 0.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.4 | 1.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) | 
| 0.4 | 1.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) | 
| 0.3 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) | 
| 0.3 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) | 
| 0.3 | 1.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) | 
| 0.3 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) | 
| 0.3 | 0.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) | 
| 0.3 | 2.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) | 
| 0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) | 
| 0.3 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) | 
| 0.3 | 2.1 | GO:0030332 | cyclin binding(GO:0030332) | 
| 0.3 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) | 
| 0.2 | 2.9 | GO:0004697 | protein kinase C activity(GO:0004697) | 
| 0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) | 
| 0.2 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) | 
| 0.2 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) | 
| 0.2 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) | 
| 0.2 | 0.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) | 
| 0.2 | 0.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) | 
| 0.2 | 1.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) | 
| 0.2 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) | 
| 0.2 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) | 
| 0.2 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) | 
| 0.2 | 0.9 | GO:0005521 | lamin binding(GO:0005521) | 
| 0.2 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) | 
| 0.2 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) | 
| 0.2 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) | 
| 0.2 | 0.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) | 
| 0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) | 
| 0.2 | 0.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) | 
| 0.2 | 0.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) | 
| 0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) | 
| 0.2 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) | 
| 0.2 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) | 
| 0.2 | 6.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) | 
| 0.2 | 3.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) | 
| 0.2 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) | 
| 0.2 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) | 
| 0.2 | 0.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) | 
| 0.1 | 3.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) | 
| 0.1 | 2.0 | GO:0031593 | polyubiquitin binding(GO:0031593) | 
| 0.1 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) | 
| 0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) | 
| 0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) | 
| 0.1 | 1.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) | 
| 0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) | 
| 0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) | 
| 0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) | 
| 0.1 | 1.6 | GO:0070412 | R-SMAD binding(GO:0070412) | 
| 0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) | 
| 0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) | 
| 0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) | 
| 0.1 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) | 
| 0.1 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) | 
| 0.1 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) | 
| 0.1 | 0.7 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) | 
| 0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) | 
| 0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) | 
| 0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) | 
| 0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) | 
| 0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) | 
| 0.1 | 3.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) | 
| 0.1 | 1.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) | 
| 0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) | 
| 0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) | 
| 0.1 | 0.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) | 
| 0.1 | 0.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) | 
| 0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) | 
| 0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) | 
| 0.1 | 0.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) | 
| 0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) | 
| 0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) | 
| 0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) | 
| 0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) | 
| 0.1 | 0.3 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) | 
| 0.1 | 2.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) | 
| 0.1 | 0.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) | 
| 0.1 | 1.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) | 
| 0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) | 
| 0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) | 
| 0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) | 
| 0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) | 
| 0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) | 
| 0.1 | 1.9 | GO:0042169 | SH2 domain binding(GO:0042169) | 
| 0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) | 
| 0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) | 
| 0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) | 
| 0.1 | 0.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) | 
| 0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) | 
| 0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) | 
| 0.1 | 0.4 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) | 
| 0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) | 
| 0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) | 
| 0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) | 
| 0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) | 
| 0.1 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) | 
| 0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) | 
| 0.1 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) | 
| 0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) | 
| 0.1 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) | 
| 0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) | 
| 0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) | 
| 0.1 | 0.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) | 
| 0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) | 
| 0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) | 
| 0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) | 
| 0.1 | 0.2 | GO:0016362 | activin receptor activity, type II(GO:0016362) | 
| 0.1 | 1.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) | 
| 0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) | 
| 0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) | 
| 0.1 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) | 
| 0.1 | 0.3 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) | 
| 0.1 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) | 
| 0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) | 
| 0.1 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) | 
| 0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) | 
| 0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) | 
| 0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) | 
| 0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) | 
| 0.1 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) | 
| 0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) | 
| 0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) | 
| 0.1 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) | 
| 0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) | 
| 0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) | 
| 0.1 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) | 
| 0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) | 
| 0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) | 
| 0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) | 
| 0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) | 
| 0.1 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) | 
| 0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) | 
| 0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) | 
| 0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) | 
| 0.1 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) | 
| 0.1 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) | 
| 0.1 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) | 
| 0.1 | 0.3 | GO:0008536 | Ran GTPase binding(GO:0008536) | 
| 0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) | 
| 0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) | 
| 0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) | 
| 0.1 | 1.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) | 
| 0.1 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) | 
| 0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) | 
| 0.1 | 0.5 | GO:0019534 | toxin transporter activity(GO:0019534) | 
| 0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) | 
| 0.1 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) | 
| 0.1 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) | 
| 0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) | 
| 0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) | 
| 0.1 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) | 
| 0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) | 
| 0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) | 
| 0.1 | 0.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) | 
| 0.1 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) | 
| 0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) | 
| 0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) | 
| 0.1 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) | 
| 0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) | 
| 0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) | 
| 0.1 | 0.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) | 
| 0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) | 
| 0.1 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) | 
| 0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) | 
| 0.1 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) | 
| 0.1 | 0.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) | 
| 0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) | 
| 0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) | 
| 0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) | 
| 0.1 | 1.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) | 
| 0.1 | 1.9 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) | 
| 0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) | 
| 0.1 | 0.3 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) | 
| 0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) | 
| 0.1 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) | 
| 0.1 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) | 
| 0.1 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) | 
| 0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) | 
| 0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) | 
| 0.1 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) | 
| 0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) | 
| 0.1 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) | 
| 0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) | 
| 0.0 | 2.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) | 
| 0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) | 
| 0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) | 
| 0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) | 
| 0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) | 
| 0.0 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) | 
| 0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) | 
| 0.0 | 0.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) | 
| 0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) | 
| 0.0 | 0.2 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) | 
| 0.0 | 1.1 | GO:0004177 | aminopeptidase activity(GO:0004177) | 
| 0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) | 
| 0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) | 
| 0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) | 
| 0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) | 
| 0.0 | 1.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) | 
| 0.0 | 0.2 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) | 
| 0.0 | 1.3 | GO:0017048 | Rho GTPase binding(GO:0017048) | 
| 0.0 | 0.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) | 
| 0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) | 
| 0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) | 
| 0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) | 
| 0.0 | 0.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) | 
| 0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) | 
| 0.0 | 0.5 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) | 
| 0.0 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) | 
| 0.0 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) | 
| 0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) | 
| 0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) | 
| 0.0 | 0.4 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) | 
| 0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) | 
| 0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) | 
| 0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) | 
| 0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) | 
| 0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) | 
| 0.0 | 0.2 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) | 
| 0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) | 
| 0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) | 
| 0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) | 
| 0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) | 
| 0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) | 
| 0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) | 
| 0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) | 
| 0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) | 
| 0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) | 
| 0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) | 
| 0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) | 
| 0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) | 
| 0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) | 
| 0.0 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) | 
| 0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) | 
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) | 
| 0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) | 
| 0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) | 
| 0.0 | 1.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) | 
| 0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) | 
| 0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) | 
| 0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) | 
| 0.0 | 0.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) | 
| 0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) | 
| 0.0 | 0.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) | 
| 0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) | 
| 0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) | 
| 0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) | 
| 0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) | 
| 0.0 | 2.5 | GO:0017124 | SH3 domain binding(GO:0017124) | 
| 0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) | 
| 0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) | 
| 0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) | 
| 0.0 | 0.8 | GO:0003724 | RNA helicase activity(GO:0003724) | 
| 0.0 | 0.0 | GO:0005035 | death receptor activity(GO:0005035) | 
| 0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) | 
| 0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) | 
| 0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) | 
| 0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) | 
| 0.0 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) | 
| 0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) | 
| 0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) | 
| 0.0 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) | 
| 0.0 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) | 
| 0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) | 
| 0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) | 
| 0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) | 
| 0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) | 
| 0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) | 
| 0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) | 
| 0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) | 
| 0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) | 
| 0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) | 
| 0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) | 
| 0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) | 
| 0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) | 
| 0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) | 
| 0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) | 
| 0.0 | 0.7 | GO:0000049 | tRNA binding(GO:0000049) | 
| 0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) | 
| 0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) | 
| 0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) | 
| 0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) | 
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) | 
| 0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) | 
| 0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) | 
| 0.0 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) | 
| 0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) | 
| 0.0 | 0.4 | GO:0010181 | FMN binding(GO:0010181) | 
| 0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) | 
| 0.0 | 0.4 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) | 
| 0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) | 
| 0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) | 
| 0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) | 
| 0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) | 
| 0.0 | 0.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) | 
| 0.0 | 0.4 | GO:0035064 | methylated histone binding(GO:0035064) | 
| 0.0 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) | 
| 0.0 | 2.9 | GO:0003690 | double-stranded DNA binding(GO:0003690) | 
| 0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) | 
| 0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) | 
| 0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) | 
| 0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) | 
| 0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) | 
| 0.0 | 0.4 | GO:0050699 | WW domain binding(GO:0050699) | 
| 0.0 | 0.1 | GO:0043236 | laminin binding(GO:0043236) | 
| 0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) | 
| 0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) | 
| 0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) | 
| 0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) | 
| 0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) | 
| 0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) | 
| 0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) | 
| 0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) | 
| 0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) | 
| 0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) | 
| 0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) | 
| 0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) | 
| 0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) | 
| 0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) | 
| 0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) | 
| 0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) | 
| 0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) | 
| 0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) | 
| 0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) | 
| 0.0 | 0.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) | 
| 0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) | 
| 0.0 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) | 
| 0.0 | 0.8 | GO:0004896 | cytokine receptor activity(GO:0004896) | 
| 0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) | 
| 0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) | 
| 0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) | 
| 0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) | 
| 0.0 | 1.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) | 
| 0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) | 
| 0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) | 
| 0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) | 
| 0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) | 
| 0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) | 
| 0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) | 
| 0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) | 
| 0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) | 
| 0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) | 
| 0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) | 
| 0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) | 
| 0.0 | 0.2 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) | 
| 0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) | 
| 0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) | 
| 0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) | 
| 0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) | 
| 0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) | 
| 0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) | 
| 0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) | 
| 0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) | 
| 0.0 | 0.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) | 
| 0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) | 
| 0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) | 
| 0.0 | 1.3 | GO:0004386 | helicase activity(GO:0004386) | 
| 0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) | 
| 0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) | 
| 0.0 | 1.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) | 
| 0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) | 
| 0.0 | 0.5 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) | 
| 0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) | 
| 0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) | 
| 0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) | 
| 0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) | 
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) | 
| 0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) | 
| 0.0 | 0.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) | 
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) | 
| 0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) | 
| 0.0 | 0.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) | 
| 0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) | 
| 0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) | 
| 0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) | 
| 0.0 | 0.6 | GO:0019825 | oxygen binding(GO:0019825) | 
| 0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) | 
| 0.0 | 0.0 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) | 
| 0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) | 
| 0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) | 
| 0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) | 
| 0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) | 
| 0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) | 
| 0.0 | 0.1 | GO:0051059 | NF-kappaB binding(GO:0051059) | 
| 0.0 | 0.0 | GO:0045159 | myosin II binding(GO:0045159) | 
| 0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) | 
| 0.0 | 2.9 | GO:0030695 | GTPase regulator activity(GO:0030695) | 
| 0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) | 
| 0.0 | 0.0 | GO:0004111 | creatine kinase activity(GO:0004111) | 
| 0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) | 
| 0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) | 
| 0.0 | 0.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) | 
| 0.0 | 0.1 | GO:0043130 | ubiquitin binding(GO:0043130) | 
| 0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) | 
| 0.0 | 0.0 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) | 
| 0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) | 
| 0.0 | 0.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) | 
| 0.0 | 0.0 | GO:0019992 | diacylglycerol binding(GO:0019992) | 
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) | 
| 0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) | 
| 0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) | 
| 0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) | 
| 0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) | 
| 0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) | 
| 0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) | 
| 0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) | 
| 0.0 | 0.7 | GO:0008565 | protein transporter activity(GO:0008565) | 
| 0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) | 
| 0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.3 | 16.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells | 
| 0.2 | 2.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. | 
| 0.2 | 2.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. | 
| 0.2 | 3.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells | 
| 0.2 | 2.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. | 
| 0.2 | 1.3 | PID IL5 PATHWAY | IL5-mediated signaling events | 
| 0.2 | 6.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | 
| 0.2 | 4.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity | 
| 0.1 | 1.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway | 
| 0.1 | 2.1 | ST G ALPHA S PATHWAY | G alpha s Pathway | 
| 0.1 | 5.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes | 
| 0.1 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway | 
| 0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway | 
| 0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events | 
| 0.1 | 2.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling | 
| 0.1 | 2.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events | 
| 0.1 | 4.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity | 
| 0.1 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin | 
| 0.1 | 1.6 | PID ARF 3PATHWAY | Arf1 pathway | 
| 0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events | 
| 0.1 | 2.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 | 
| 0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K | 
| 0.1 | 1.5 | PID MYC PATHWAY | C-MYC pathway | 
| 0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta | 
| 0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events | 
| 0.1 | 2.9 | PID IL4 2PATHWAY | IL4-mediated signaling events | 
| 0.1 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 | 
| 0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway | 
| 0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events | 
| 0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway | 
| 0.1 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling | 
| 0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events | 
| 0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 | 
| 0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling | 
| 0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL | 
| 0.1 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events | 
| 0.1 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling | 
| 0.1 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells | 
| 0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway | 
| 0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin | 
| 0.0 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport | 
| 0.0 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha | 
| 0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling | 
| 0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma | 
| 0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling | 
| 0.0 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events | 
| 0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes | 
| 0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. | 
| 0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway | 
| 0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling | 
| 0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway | 
| 0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta | 
| 0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling | 
| 0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network | 
| 0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase | 
| 0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction | 
| 0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes | 
| 0.0 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling | 
| 0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining | 
| 0.0 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway | 
| 0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events | 
| 0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones | 
| 0.0 | 1.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase | 
| 0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway | 
| 0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling | 
| 0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins | 
| 0.0 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis | 
| 0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription | 
| 0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events | 
| 0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway | 
| 0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms | 
| 0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network | 
| 0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network | 
| 0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events | 
| 0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway | 
| 0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells | 
| 0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway | 
| 0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway | 
| 0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans | 
| 0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks | 
| 0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling | 
| 0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway | 
| 0.0 | 0.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. | 
| 0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. | 
| 0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events | 
| 0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway | 
| 0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events | 
| 0.0 | 0.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity | 
| 0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling | 
| 0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network | 
| 0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. | 
| 0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.5 | 4.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions | 
| 0.3 | 4.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains | 
| 0.3 | 4.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules | 
| 0.2 | 1.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway | 
| 0.2 | 3.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling | 
| 0.2 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade | 
| 0.2 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels | 
| 0.2 | 1.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway | 
| 0.2 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation | 
| 0.2 | 3.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling | 
| 0.2 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling | 
| 0.2 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion | 
| 0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex | 
| 0.1 | 3.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation | 
| 0.1 | 5.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling | 
| 0.1 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers | 
| 0.1 | 2.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis | 
| 0.1 | 2.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 | 
| 0.1 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac | 
| 0.1 | 2.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA | 
| 0.1 | 1.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins | 
| 0.1 | 2.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling | 
| 0.1 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling | 
| 0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane | 
| 0.1 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi | 
| 0.1 | 1.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling | 
| 0.1 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane | 
| 0.1 | 1.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks | 
| 0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors | 
| 0.1 | 1.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity | 
| 0.1 | 1.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 
| 0.1 | 1.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression | 
| 0.1 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis | 
| 0.1 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 
| 0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G | 
| 0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane | 
| 0.1 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events | 
| 0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) | 
| 0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 
| 0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide | 
| 0.1 | 3.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 
| 0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection | 
| 0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) | 
| 0.1 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway | 
| 0.1 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling | 
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE | 
| 0.1 | 0.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation | 
| 0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | 
| 0.1 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex | 
| 0.1 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors | 
| 0.1 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells | 
| 0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins | 
| 0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex | 
| 0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease | 
| 0.1 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling | 
| 0.1 | 0.7 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA | 
| 0.1 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins | 
| 0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport | 
| 0.1 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha | 
| 0.1 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins | 
| 0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN | 
| 0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | 
| 0.1 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling | 
| 0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis | 
| 0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis | 
| 0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism | 
| 0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors | 
| 0.0 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins | 
| 0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis | 
| 0.0 | 1.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling | 
| 0.0 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation | 
| 0.0 | 0.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing | 
| 0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions | 
| 0.0 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways | 
| 0.0 | 1.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis | 
| 0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling | 
| 0.0 | 0.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation | 
| 0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network | 
| 0.0 | 0.3 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex | 
| 0.0 | 0.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis | 
| 0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL | 
| 0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | 
| 0.0 | 0.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines | 
| 0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) | 
| 0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock | 
| 0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation | 
| 0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 
| 0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway | 
| 0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport | 
| 0.0 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins | 
| 0.0 | 0.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE | 
| 0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis | 
| 0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors | 
| 0.0 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling | 
| 0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin | 
| 0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C | 
| 0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family | 
| 0.0 | 1.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling | 
| 0.0 | 0.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling | 
| 0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation | 
| 0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones | 
| 0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation | 
| 0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation | 
| 0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions | 
| 0.0 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor | 
| 0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events | 
| 0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases | 
| 0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle | 
| 0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response | 
| 0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis | 
| 0.0 | 1.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 
| 0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions | 
| 0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects | 
| 0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes | 
| 0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 
| 0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation | 
| 0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins | 
| 0.0 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction | 
| 0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 
| 0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins | 
| 0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA | 
| 0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 | 
| 0.0 | 0.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport | 
| 0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER | 
| 0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline | 
| 0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport | 
| 0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors | 
| 0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation | 
| 0.0 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 | 
| 0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels | 
| 0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters | 
| 0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 | 
| 0.0 | 0.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation | 
| 0.0 | 0.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism | 
| 0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) | 
| 0.0 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins | 
| 0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth | 
| 0.0 | 0.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway | 
| 0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation | 
| 0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules | 
| 0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression | 
| 0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage | 
| 0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism | 
| 0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors | 
| 0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival | 
| 0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |